Recruiting
Phase 1
Phase 2

RNA-LP Vaccines

Sponsor:

University of Florida

Code:

NCT04573140

Conditions

Adult Glioblastoma

High Grade Glioma

WHO Grade III or IV Malignant Glioma

Eligibility Criteria

Sex: All

Age: 4+

Healthy Volunteers: Not accepted

Interventions

Autologous total tumor mRNA and pp65 full length (fl) lysosomal associated membrane protein (LAMP) mRNA loaded DOTAP liposome vaccine administered intravenously (RNA loaded lipid particles, RNA-LPs)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by University of Florida on 2025-03-04.